“Global Ophthalmic Drugs market set to grow to $32bn by 2024” says Visiongain report

15 August 2019
Pharma

Visiongain has launched a new pharma report Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029: Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs.

A specialist sector within the overall pharmaceutical industry, the ophthalmic drugs market is dominated by a relatively small number of companies. The market is relatively mature though with opportunities for growth in key therapeutic areas. Key patent expirations have affected revenues in this market in recent years, particularly in the glaucoma segment.

The lead analyst of the report commented "Successful harnessing of the opportunities for growth in the ophthalmic pharmaceuticals market will depend upon the development of novel products with technologies that increase clinical effectiveness and development of products for previously-untreated ophthalmic conditions. Products based on superior technology, particularly those technologies that increase clinical effectiveness or increase patient compliance, are more likely to succeed."

Leading companies featured in the report include Akorn, Allergan, Bayer, Novartis, Pfizer, Regeneron, Roche, Santen Pharmaceuticals, Senju, Valeant and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Respiratory Inhalers market set to grow to $41bn by 2025” says new Visiongain report

Emerging countries will experience accelerated growth in the respiratory inhaler market, due to higher standards of living, rising life expectancy and an increase in urbanization.

28 January 2020

Read

“Pharmaceutical Glass Packaging Market Over USD 20.1 billion in 2020”, says Visiongain report

Visiongain’s new report the Pharmaceutical Glass Packaging Market Report 2020-2030: Forecasts by Product (Vials, Bottles, Cartridges & Syringes, Ampoules) plus analysis of leading companies indicates that the global Pharmaceutical Glass Packaging market will grow at a CAGR over 6% by 2030. It is anticipated that high demand from the pharmaceutical industry and widespread use of generic injectable drugs would drive …

24 January 2020

Read

“Global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030”, says Visiongain

Visiongain’s new report the Pharmaceutical Cartridges Market Report 2020-2030: Forecasts by Material (Glass and Plastic) plus analysis of leading companies indicates that the global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030. It is anticipated that ongoing clinical trials to validate newly developed customized nutritional algorithms will help maintain the dominance of this regional market throughout …

24 January 2020

Read

“Global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030”, says Visiongain

Visiongain’s new report the Pharmaceutical Cartridges Market Report 2020-2030: Forecasts by Material (Glass and Plastic) plus analysis of leading companies indicates that the global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030. It is anticipated that ongoing clinical trials to validate newly developed customized nutritional algorithms will help maintain the dominance of this regional market throughout …

24 January 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever